Avenue Therapeutics Inc
Save
3.64M
Market cap
0.07x
Current P/E
17.99x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.
Similar securities
Based on sector and market capitalization
Report issue